This post has been archived and contains information that may be out of date.
Based on requests from stakeholders, including CHA, the Department of Health Care Services has released guidance on the reimbursement requirements associated with the California Advancing and Innovating Medi-Cal (CalAIM) major organ transplant changes.
This content is restricted to members.
